Six top tips to prepare for the new EU Clinical Trial Regulation

Published on: Apr 13, 2021

The European Union Clinical Trial Regulation 536/2014 (EU-CTR) aims to standardize and harmonize the conduct and management of interventional clinical trials across the European Economic Area (EEA), with legally binding rules on requirements and increased transparency. The new EU-CTR promises a simplified process designed to decrease the burden resulting from idiosyncratic interpretations of the current EU-CTD. But to reap efficiencies, sponsors must sow operational changes. This article covers the six essential preparations companies should undertake now.


Open PDF

Return to Insights Center

Related Insights

Blog

Adoption of the ICH Q12 guideline: New Horizons for Efficient Product Supply Chain Management for a Key Global Market

Nov 13, 2023

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Article

Expedited Pathways Comparisons - US EU CHN

Oct 19, 2021

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Blog

Ensuring future success in a new market by delivering a robust safety database solution

Aug 4, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Article

The technologies that are reshaping biotherapeutics manufacturing, an EU perspective

Jul 6, 2023

Whitepaper

How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU

Jun 28, 2023

Blog

Population variability: important considerations in vaccine development

Jun 14, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Webinar

Accelerate global drug development: Leveraging China regulatory changes

Aug 15, 2025

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Related Insights

Blog

Adoption of the ICH Q12 guideline: New Horizons for Efficient Product Supply Chain Management for a Key Global Market

Nov 13, 2023

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Article

Expedited Pathways Comparisons - US EU CHN

Oct 19, 2021

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Blog

Ensuring future success in a new market by delivering a robust safety database solution

Aug 4, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Show more